NYSDH approval enables Rosetta Genomics to offer its proprietary microRNA diagnostic for identification of four major subtypes of kidney cancer in all 50 US states.
Acquisition of leading regulatory firm in molecular diagnostics strengthens Illumina’s readiness for further expansion into clinical applications of next-generation sequencing.
The TransferMan 4r micromanipulator from Eppendorf North America, Hauppauge, NY, provides an intuitive user interface while enabling precise microinjection and direct transmission of movement.
The Appistry Pipeline Challenge will reward and support one winning proposal for a creative next-generation sequencing pipeline that will make a difference in clinical research and precision medicine.
Although enacted primarily as the annual “doc fix” to prevent severe cuts in the Medicare rates for physicians, the Protecting Access to Medicare Act of 2014 also embodies the first serious effort in 30 years to legislate a reform of the Centers for Medicare and Medicaid Services Clinical Laboratory Fee Schedule.
TGI will build on transplant diagnostics patent rights co-owned by Northwestern University and the Scripps Research Institute to develop and commercialize genomics-based tests to improve organ transplant outcomes.
With recent action by the New York State Department of Health, CombiMatrix now markets two SNP-based genetic analysis tests in New York.
Greiner Bio-One will be giving away a number of prizes at its booth during next week’s AACC conference, including a Microsoft Surface tablet.
At the business unit’s first outing at AACC, Beckman Coulter Life Sciences will promote its contract manufacturing services, producing antibody cocktails tailored to client specifications.
In conjunction with the upcoming AACC meeting in Chicago, Bio-Rad Laboratories and Sysmex America will host a presentation focusing on how laboratories can implement automation to yield high-quality A1c results.